GGrantIndex
← Search

10 Biostatistics Resource Group

$5,456P30FY2019CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Linked publications, trials & patents

Trial NCT07407920Trial NCT07349641Trial NCT06651580Trial NCT05681026Trial NCT05223036Trial NCT05078866Trial NCT05057312Trial NCT05054296Trial NCT05044546Trial NCT05023967Trial NCT05011045Trial NCT04875728Trial NCT04870645Trial NCT04810091Trial NCT04751422Trial NCT04740164Trial NCT04668300Trial NCT04615013Trial NCT04505267Trial NCT04484909Trial NCT04483349Trial NCT04481204Trial NCT04474301Trial NCT04458610Trial NCT04447222Trial NCT04435691Trial NCT04430725Trial NCT04407247Trial NCT04373720Trial NCT04317781Trial NCT04311723Trial NCT04310826Trial NCT04310397Trial NCT04265430Trial NCT04257045Trial NCT04256941Trial NCT04239989Trial NCT04239976Trial NCT04239157Trial NCT04236882Trial NCT04228042Trial NCT04220827Trial NCT04220775Trial NCT04220008Trial NCT04219969Trial NCT04219904Trial NCT04216732Trial NCT04216563Trial NCT04216524Trial NCT04216472Trial NCT04215029Trial NCT04200534Trial NCT04199026Trial NCT04196972Trial NCT04189783Trial NCT04189770Trial NCT04189757Trial NCT04188418Trial NCT04188405Trial NCT04186884Trial NCT04186832Trial NCT04185337Trial NCT04181463Trial NCT04171622Trial NCT04171219Trial NCT04171037Trial NCT04169763Trial NCT04169737Trial NCT04169542Trial NCT04160052Trial NCT04151082Trial NCT04150939Trial NCT04140487Trial NCT04135326Trial NCT04134208Trial NCT04132843Trial NCT04132505Trial NCT04132440Trial NCT04129138Trial NCT04128748Trial NCT04128501Trial NCT04127721Trial NCT04125914Trial NCT04119037Trial NCT04106843Trial NCT04106245Trial NCT04090619Trial NCT04090567Trial NCT04087057Trial NCT04083378Trial NCT04082572Trial NCT04074746Trial NCT04066894Trial NCT04062305Trial NCT04062266Trial NCT04058964Trial NCT04054245Trial NCT04054167Trial NCT04054154Trial NCT04053517

Abstract

PROJECT SUMMARY: BIOSTATISTICS RESOURCE GROUP (BRG) The mission of the Biostatistics Resource Group (BRG) is to enhance the scientific excellence of research at MD Anderson through outstanding statistical designs and methods, including the proper and efficient use of standard and cutting-edge methods and the development of novel methods; and to train and mentor future biostatisticians through an innovative, relevant curriculum and through exposure to unique data sets, the latest research methodology and findings, and state-of-the-art computing technology. BRG faculty mentor postdoctoral fellows and participate in 3 formal doctoral degree programs, teaching courses and advising graduate researchers: (i) Quantitative Sciences at MD Anderson-UTHealth Graduate School of Biomedical Sciences; (ii) Interinstitutional Graduate Program in Biostatistics for Cancer Research, a joint effort with the Department of Statistics at Rice University; and (iii) a joint effort with Texas A&M University. Director Dr. J. Jack Lee and co-directors Dr. Yu Shen and Ms. Marcella Johnson lead the BRG, which contributes to rigor and reproducibility at the institution by holding weekly consensus reviews of all clinical and research protocols submitted for scientific review (except those with prior NIH approval and those submitted directly to the institutional review board [IRB]), collaborating in the design of all clinical trials initiated at MD Anderson, conducting the data analyses, and following operating procedures that facilitate reproducibility. The status of the BRG within an independent, quantitative science group ensures the objective assessment of research. A faculty member and statistical analyst team are assigned as the primary contacts for each research and clinical department within the institution, which fosters close collaboration and subject matter expertise within the assigned teams. Protocols and trials are evaluated before they are reviewed by the IRB to protect the scientific integrity of MD Anderson and the quality of patient care and laboratory animal use. All BRG faculty members and statistical analysts are available to collaborate or consult with clinical and laboratory-based researchers. The BRG provides added value through (i) Bayesian approaches to inference, adaptive randomization in clinical trials, and statistical and graphical modeling; (ii) Clinical Trial Conduct, a centralized collection of BRG-designed databases, web applications, and web services that support the conduct of clinical trials; and (iii) software programs to support clinical trial management, which are documented and distributed online to researchers around the world at no cost. During the past 6 years, the BRG supported 1,097 center members representing all CCSG programs and contributed to more than 1500 papers, 577 (38%) with IF >5 and 175 (11%) with IF >10. In grant Yr42, BRG utilization increased 20% compared with the previous 5-year average, and peer review-funded usage accounted for 77%. In Yr43, the institution contributed 44% ($3,337,751) of the total BRG operating expenses; other grant allocations covered 48% ($3,697,124), and CCSG funds provided 8% ($611,160). For Yr44, the BRG requests $629,456 (a 3% increase, but 7% of the total BRG operating expenses) from the CCSG.

View original record on NIH RePORTER →